4th Quarter - Report

W STRATEGIES, LLC for MEDIMMUNE, LLC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Educated staff about RSV prophylaxis, including cost effectiveness research studies being developed at CDC. H.R. 3671: Consolidated Appropriations Act, 2012 as it relates to funding for cost effectiveness research on RSV prophylaxis at the CDC.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3671 (112th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.